ABVX vs REGN: Which Stock is Better?
Side-by-side comparison of Abivax Sa and Regeneron Pharmaceuticals Inc in 2026
ABVX
Abivax Sa
$118.84
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | ABVX | REGN | Winner |
|---|---|---|---|
| Market Cap | $8.19B | $77.69B | REGN |
| P/E Ratio | N/A | 17.57 | REGN |
| EPS (TTM) | $N/A | $41.71 | REGN |
| Revenue Growth | -0.8% | 0.0% | REGN |
| Gross Margin | 100.0% | 45.8% | ABVX |
Analyze ABVX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABVX or REGN a better investment?
Comparing ABVX and REGN: Abivax Sa has a market cap of $8.19B while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABVX and REGN?
ABVX (Abivax Sa) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABVX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABVX or REGN?
REGN has higher revenue growth at 0.0% vs -0.8% for ABVX.
Which company is more profitable: ABVX or REGN?
Abivax Sa (ABVX) has higher gross margins at 100.0% compared to 45.8% for REGN.
Which is the larger company: ABVX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $8.19B for ABVX.
Should I buy ABVX or REGN in 2026?
Both ABVX and REGN have investment merit. ABVX trades at $118.84 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABVX and REGN stock?
Key differences: Market Cap ($8.19B vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 45.8%).